Phase I trial of adjuvant autogene cevumeran, an individualized mRNA neoantigen vaccine, for pancreatic ductal adenocarcinoma Meeting Abstract
| Authors: | Balachandran, V. P.; Rojas, L. A.; Sethna, Z.; Soares, K.; Derhovanessian, E.; Mueller, F.; Yadav, M.; Basturk, O.; Gonen, M.; Wei, A. C. C.; D'Angelica, M. I.; Kingham, T. P.; Greenbaum, B.; Merghoub, T.; Jarnagin, W. R.; Drebin, J. A.; Sahin, U.; Tuereci, O.; Wolchok, J. D.; O'Reilly, E. M. |
| Abstract Title: | Phase I trial of adjuvant autogene cevumeran, an individualized mRNA neoantigen vaccine, for pancreatic ductal adenocarcinoma |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680300740 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.2516 |
| Notes: | Meeting Abstract: 2516 -- This meeting was also held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
